Nuvectis Pharma, Inc. (NVCT)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 240.20M |
| Enterprise value | 215.60M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 11.81 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -9.54 |
Trading information
Stock price history
| Beta (5Y monthly) | N/A |
| 52-week change 3 | 77.82% |
| S&P500 52-week change 3 | 18.47% |
| 52-week high 3 | 18.65 |
| 52-week low 3 | 6.21 |
| 50-day moving average 3 | 14.43 |
| 200-day moving average 3 | 12.95 |
Share statistics
| Avg vol (3-month) 3 | 42.51k |
| Avg vol (10-day) 3 | 76.07k |
| Shares outstanding 5 | 17.23M |
| Implied shares outstanding 6 | 17.23M |
| Float 8 | 4.23M |
| % held by insiders 1 | 60.34% |
| % held by institutions 1 | 15.00% |
| Shares short (30 Aug 2023) 4 | 172.95k |
| Short ratio (30 Aug 2023) 4 | 4.91 |
| Short % of float (30 Aug 2023) 4 | 1.99% |
| Short % of shares outstanding (30 Aug 2023) 4 | 1.00% |
| Shares short (prior month 30 July 2023) 4 | 317.26k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2022 |
| Most-recent quarter (mrq) | 29 June 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -68.24% |
| Return on equity (ttm) | -140.30% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | N/A |
| Net income avi to common (ttm) | -22.33M |
| Diluted EPS (ttm) | -1.51 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 24.6M |
| Total cash per share (mrq) | 1.43 |
| Total debt (mrq) | N/A |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 5.41 |
| Book value per share (mrq) | 1.18 |
Cash flow statement
| Operating cash flow (ttm) | -16.8M |
| Levered free cash flow (ttm) | -7.77M |
© 2023 Yahoo. All rights reserved.
